business template

978-93-94174-20-7_2

Development of Biogenic Nanomaterials and their Benign Applications pp 16-25
Editors: Dr. R. Balachandar
Dr. K. Ashok Kumar (2022)
ISBN: 978-93-94174-20-7
doi: https://doi.org/10.20546/978-93-94174-20-7_2
Chapter 2
Biosynthesized Nanomaterials – Anticancer
V. Keerthivasan, Muthusamy Suganthi, Gopalakrishnan Abirami1 and Malaiyandi Jayanthi
Department of Biotechnology, Vels Institute of Science Technology and Advanced Studies, Pallavaram, Chennai – 600 117, India
Abstract
One way to use nanomaterial as anticancer agents is to use nanoparticles to deliver chemotherapy medication directly to cancer cells. This method reduces toxicity to healthy cells, improves therapeutic efficacy, and increases bioavailability. Liposomes have effectively delivered doxorubicin and paclitaxel to cancer cells in clinical trials. Another way to use nanomaterials as anticancer medicines is to use their unique physical and chemical properties to specifically target cancer cells. Gold nanoparticles containing antibody that binds to cancer cells can be given to the tumour site. Gold nanoparticles can deliver drugs or generate heat for photothermal treatment, which selectively kills cancer cells.
Keywords
Nanomaterial, Anticancer, Liposomes, Doxorubicin, Gold nanoparticles, Bioavailability
*Corresponding author; e-mail: rsjaya24@gmail.com
Cite this Chapter: Keerthivasan, V., Muthusamy Suganthi, Gopalakrishnan Abirami and Malaiyandi Jayanthi. 2023. Biosynthesized Nanomaterials – Anticancer. In: R. Balachandar and K. Ashok Kumar (Eds.), Development of Biogenic Nanomaterials and their Benign Applications. Excellent Publishers, India. pp. 16-25. doi: https://doi.org/10.20546/978-93-94174-20-7_2
Image 03